KYTX
Kyverna Therapeutics Inc.
$6.25
-$0.27(-4.14%)
41
Overall
--
Value
41
Tech
--
Quality
Market Cap
$250.82M
Volume
663.26K
52W Range
$1.78 - $7.20
Target Price
$18.20
Key Metrics Overview
| Market Cap | $250.82M | P/E Ratio | N/A |
| 52W High | $7.20 | 52W Low | $1.78 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 77.1% | 52W Position | 82.5% |
| Overall Score | 41 | Value Score | -- |
| Quality Score | -- | Technical Score | 41 |
Growth Analysis
| EPS Current Est | $-3.86 | EPS Next Est | $-3.67 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYTX | $6.25 | -4.1% | 663.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kyverna Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW